Your browser doesn't support javascript.
loading
FKBP51 inhibits GSK3ß and augments the effects of distinct psychotropic medications.
Gassen, N C; Hartmann, J; Zannas, A S; Kretzschmar, A; Zschocke, J; Maccarrone, G; Hafner, K; Zellner, A; Kollmannsberger, L K; Wagner, K V; Mehta, D; Kloiber, S; Turck, C W; Lucae, S; Chrousos, G P; Holsboer, F; Binder, E B; Ising, M; Schmidt, M V; Rein, T.
Affiliation
  • Gassen NC; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Hartmann J; Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
  • Zannas AS; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Kretzschmar A; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
  • Zschocke J; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Maccarrone G; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Hafner K; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Zellner A; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Kollmannsberger LK; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Wagner KV; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Mehta D; Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
  • Kloiber S; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Turck CW; Department of Clinical Research, Max Planck Institute of Psychiatry, Munich, Germany.
  • Lucae S; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Chrousos GP; Department of Clinical Research, Max Planck Institute of Psychiatry, Munich, Germany.
  • Holsboer F; First Department of Pediatrics, University of Athens Medical School, Athens, Greece.
  • Binder EB; Department of Clinical Research, Max Planck Institute of Psychiatry, Munich, Germany.
  • Ising M; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Schmidt MV; Department of Psychiatry and Behavioral Sciences, Emory University, Max Planck Institute of Psychiatry, Munich, Germany.
  • Rein T; Department of Clinical Research, Max Planck Institute of Psychiatry, Munich, Germany.
Mol Psychiatry ; 21(2): 277-89, 2016 Feb.
Article in En | MEDLINE | ID: mdl-25849320
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus Binding Proteins / Glycogen Synthase Kinase 3 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: Mol Psychiatry Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus Binding Proteins / Glycogen Synthase Kinase 3 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: Mol Psychiatry Year: 2016 Document type: Article